Succinic Acid

Succinic Acid

SCHEMBL105515

C[N+](C)(C)C.C[N+](C)(C)C.O=C([O-])CCC(=O)[O-]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 2/20 0.56
HDAC3 O15379 2/20 0.56
HDAC1 Q13547 2/20 0.56
HDAC2 Q92769 2/20 0.56
HDAC8 Q9BY41 2/20 0.56
BBOX1 O75936 10/20 0.55
CA1 P00915 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL105516 0.88 LMNA (0.50) FFAR3HDAC3HDAC1HDAC2HDAC8
Levulinic Acid SCHEMBL357248 0.88 ALDH1A1 (0.56) FFAR3HDAC3HDAC1HDAC2HDAC8
Adipic Acid SCHEMBL106656 0.87 BBOX1 (0.58) FFAR3HDAC3HDAC1HDAC2HDAC8
Glutarate SCHEMBL104188 0.87 BBOX1 (0.58) FFAR3HDAC3HDAC1HDAC2HDAC8
Succinic Acid SCHEMBL18166887 0.85 FFAR3 (0.53) FFAR3HDAC3HDAC1HDAC2HDAC8
Sebacic Acid SCHEMBL5874500 0.84 BBOX1 (0.56) FFAR3HDAC3HDAC1HDAC2HDAC8
Tetramethylammonium Ion SCHEMBL8438225 0.84 BBOX1 (0.56) FFAR3HDAC3HDAC1HDAC2HDAC8
Adipic Acid SCHEMBL8028995 0.84 BBOX1 (0.56) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL109152 0.84 FFAR3 (0.82) FFAR3HDAC3HDAC1HDAC2HDAC8
Succinic Acid SCHEMBL28871070 0.81 FFAR3 (0.59) FFAR3HDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260071024-A1 POLYPROPIOLACTONES AND METHODS OF PREPARATION NOVOMER INC (US) 2026-03-12 US claimed
EP-4323425-A1 POLYPROPIOLACTONES AND METHODS OF PREPARATION Novomer, Inc. (US) 2024-02-21 EP claimed
CN-117157342-A Polypropylene lactone and preparation method 诺沃梅尔公司 2023-12-01 CN claimed
WO-2022221266-A1 POLYPROPIOLACTONES AND METHODS OF PREPARATION NOVOMER, INC. (US) 2022-10-20 WO claimed
US-10246558-B2 Compositions comprising siloxane compounds and methods for using the same MILLIKEN & COMPANY (US) 2019-04-02 US claimed
EP-3458498-A1 COMPOSITIONS COMPRISING SILOXANE COMPOUNDS AND METHODS FOR USING THE SAME Milliken & Company (US) 2019-03-27 EP claimed
WO-2017201035-A1 COMPOSITIONS COMPRISING SILOXANE COMPOUNDS AND METHODS FOR USING THE SAME MILLIKEN & COMPANY (US) 2017-11-23 WO claimed
US-20170335065-A1 COMPOSITIONS COMPRISING SILOXANE COMPOUNDS AND METHODS FOR USING THE SAME MILLIKEN & COMPANY 2017-11-23 US claimed
US-5393386-A Method for preparing aqueous quaternary ammonium hydroxide solution MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1995-02-28 US claimed
JP-6248065-A None JP disclosed
US-20260071024-A1 POLYPROPIOLACTONES AND METHODS OF PREPARATION NOVOMER INC (US) 2026-03-12 US disclosed
US-12338318-B2 Polypropiolactones and methods of preparation NOVOMER, INC. (US) 2025-06-24 US disclosed
US-20240228695-A1 POLYPROPIOLACTONES AND METHODS OF PREPARATION NOVOMER INC (US) 2024-07-11 US disclosed
EP-4323425-A1 POLYPROPIOLACTONES AND METHODS OF PREPARATION Novomer, Inc. (US) 2024-02-21 EP disclosed
EP-0608545-B1 Method for preparing aqueous quaternary ammonium hydroxide solution MITSUBISHI GAS CHEMICAL CO (JP) 1997-04-16 EP disclosed
EP-0708452-A1 Ion-conductive polymer electrolyte, method for producing the electrolyte and capacitors using the electrolyte MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1996-04-24 EP disclosed
US-5393386-A Method for preparing aqueous quaternary ammonium hydroxide solution MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1995-02-28 US disclosed
JP-H06248065-A POLYMERIZATION INITIATOR FOR 2-OXETANONE AND PRODUCTION OF POLY(2-OXETANONE) TOKUYAMA SODA CO LTD 1994-09-06 JP disclosed
EP-0608545-A1 Method for preparing aqueous quaternary ammonium hydroxide solution MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1994-08-03 EP disclosed
US-4915861-A DICARBOXYLIC ACID SALT OF TETRAMETHYLAMMONIUM NIPPON CHEMI-CON CORPORATION (JP) 1990-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071024-A1 POLYPROPIOLACTONES AND METHODS OF PREPARATION NOTUM, ALKBH3, EBP FFAR3 177/4885HDAC3 1967/4885HDAC1 1957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.